                               SEQUENCE LISTING

<110> THE GENERAL HOSPITAL CORPORATION
 
<120> METHODS AND COMPOSITIONS FOR TREATING A BRAIN INJURY

<130> 030258-088941-PCT

<140> PCT/US2018/018537
<141> 2018-02-17

<150> 62/460,229
<151> 2017-02-17

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 576
<212> DNA
<213> Homo sapiens

<400> 1
atgtattcaa cagtatctgg atcagaaaaa aattccaaaa tttattgtcc taccattgac       60

ctctacaact ggacagcacc tcttgagtgg tttaagaatt gtcaggctct tcaaggatca      120

aggtacaggg cgcacaagtc atttttggtc attgataatg tgatgactga ggacgcaggt      180

gattacacct gtaaatttat acacaatgaa aatggagcca attatagtgt gacggcgacc      240

aggtccttca cggtcaagga tgagcaaggc ttttctctgt ttccagtaat cggagcccct      300

gcacaaaatg aaataaagga agtggaaatt ggaaaaaacg caaacctaac ttgctctgct      360

tgttttggaa aaggcactca gttcttggct gccgtcctgt ggcagcttaa tggaacaaaa      420

attacagact ttggtgaacc aagaattcaa caagaggaag ggcaaaatca aagtttcagc      480

aatgggctgg cttgtctaga catggtttta agaatagctg acgtgaagga agaggattta      540

ttgctgcagt acgactgtct ggccctgaat ttctga                                576


<210> 2
<211> 687
<212> DNA
<213> Homo sapiens

<400> 2
atgaagccta aaatgaagta ttcaaccaac aaaatttcca cagcaaagtg gaagaacaca       60

gcaagcaaag ccttgtgttt caagctggga aaatcccaac agaaggccaa agaagtttgc      120

cccatgtact ttatgaagct ccgctctggc cttatgataa aaaaggaggc ctgttacttt      180

aggagagaaa ccaccaaaag gccttcactg aaaacaggta gaaagcacaa aagacatctg      240

gtactcgctg cctgtcaaca gcagtctact gtggagtgct ttgcctttgg tatatcaggg      300

gtccagaaat atactagagc acttcatgat tcaagtatca cagataaggt gttactgagt      360

tactatgagt ctcaacaccc ctcaaatgaa tcaggtgacg gtgttgatgg taagatgtta      420

atggtaaccc tgagtcctac aaaagacttc tggttgcatg ccaacaacaa ggaacactct      480

gtggagctcc ataagtgtga aaaaccactg ccagaccagg ccttctttgt ccttcataat      540

atgcactcca actgtgtttc atttgaatgc aagactgatc ctggagtgtt tataggtgta      600

aaggataatc atcttgctct gattaaagta gactcttctg agaatttgtg tactgaaaat      660

atcttgttta agctctctga aacttag                                          687


<210> 3
<211> 211
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Met Tyr Ser Thr Val Ser Gly Ser Glu Lys Asn Ser Lys Ile Tyr Cys 
1               5                   10                  15      


Pro Thr Ile Asp Leu Tyr Asn Trp Thr Ala Pro Leu Glu Trp Phe Lys 
            20                  25                  30          


Asn Cys Gln Ala Leu Gln Gly Ser Arg Tyr Arg Ala His Lys Ser Phe 
        35                  40                  45              


Leu Val Ile Asp Asn Val Met Thr Glu Asp Ala Gly Asp Tyr Thr Cys 
    50                  55                  60                  


Lys Phe Ile His Asn Glu Asn Gly Ala Asn Tyr Ser Val Thr Ala Thr 
65                  70                  75                  80  


Arg Ser Phe Thr Val Lys Asp Glu Gln Gly Phe Ser Leu Phe Pro Val 
                85                  90                  95      


Ile Gly Ala Pro Ala Gln Asn Glu Ile Lys Glu Val Glu Ile Gly Lys 
            100                 105                 110         


Asn Ala Asn Leu Thr Cys Ser Ala Cys Phe Gly Lys Gly Thr Gln Phe 
        115                 120                 125             


Leu Ala Ala Val Leu Trp Gln Leu Asn Gly Thr Lys Ile Thr Asp Phe 
    130                 135                 140                 


Gly Glu Pro Arg Ile Gln Gln Glu Glu Gly Gln Asn Gln Ser Phe Ser 
145                 150                 155                 160 


Asn Gly Leu Ala Cys Leu Asp Met Val Leu Arg Ile Ala Asp Val Lys 
                165                 170                 175     


Glu Glu Asp Leu Leu Leu Gln Tyr Asp Cys Leu Ala Leu Asn Leu His 
            180                 185                 190         


Gly Leu Arg Arg His Thr Val Arg Leu Ser Arg Lys Asn Pro Ser Lys 
        195                 200                 205             


Glu Cys Phe 
    210     


